APA (7th ed.) Citation

U, K., A, M., D, v. d. H., L, B., A, B., R, B., . . . J, B. (2025). Discriminating capacity of the ASAS health index in patients with axial spondyloarthritis treated with ixekizumab. Seminars in arthritis and rheumatism, 74, 152777. https://doi.org/10.1016/j.semarthrit.2025.152777

Chicago Style (17th ed.) Citation

U, Kiltz, et al. "Discriminating Capacity of the ASAS Health Index in Patients with Axial Spondyloarthritis Treated with Ixekizumab." Seminars in Arthritis and Rheumatism 74 (2025): 152777. https://doi.org/10.1016/j.semarthrit.2025.152777.

MLA (9th ed.) Citation

U, Kiltz, et al. "Discriminating Capacity of the ASAS Health Index in Patients with Axial Spondyloarthritis Treated with Ixekizumab." Seminars in Arthritis and Rheumatism, vol. 74, 2025, p. 152777, https://doi.org/10.1016/j.semarthrit.2025.152777.